Markets◆ Mixed
Lab Rats series: A Bengaluru startup’s bid to drug the undruggable
· LiveMint Companies
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.